MitoLab
Allston
About MitoLab
MitoLab is a biotechnology company building a scalable platform for mitochondrial genome engineering. It creates and sells products for use in non-clinical scientific research scenarios. The company’s products are designed to be used in non-clinical research projects assessing the utility of chemical compounds for mitochondrial medicine. Their customers range from multinational companies to individuals specializing in mitochondrial, metabolic, and anti-aging research. Founded by Fahim Farzadfard and Louis J. Kang in 2020 and is headquartered in Allston, Massachusetts, USA.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.7M
- Last round: Series Unknown (Apr 2020)
- Website: mitolab.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/mitolab-38275 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.